181 related articles for article (PubMed ID: 28273272)
1. Vortioxetine-induced manic mood switch in patient with previously unknown bipolar disorder.
Sobreira G; Oliveira J; Brissos S
Braz J Psychiatry; 2017; 39(1):86. PubMed ID: 28273272
[No Abstract] [Full Text] [Related]
2. Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction.
Jacobsen PL; Mahableshwarkar AR; Chen Y; Chrones L; Clayton AH
J Sex Med; 2015 Oct; 12(10):2036-48. PubMed ID: 26331383
[TBL] [Abstract][Full Text] [Related]
3. Behavioral disinhibition without persistent mood elevation after high dose citalopram treatment.
Rocha FF; Correa H; Lage NV
Braz J Psychiatry; 2007 Dec; 29(4):384-5. PubMed ID: 18200405
[No Abstract] [Full Text] [Related]
4. Possible mild serotonin syndrome related to co-prescription of tandospirone and trazodone.
Kaneda Y; Ohmori T; Okabe H
Gen Hosp Psychiatry; 2001; 23(2):98-101. PubMed ID: 11354048
[No Abstract] [Full Text] [Related]
5. A new case of fluoxetine-induced mania in poststroke depression.
Kulisevsky J; Berthier ML
Clin Neuropharmacol; 1997 Apr; 20(2):180-1. PubMed ID: 9099474
[No Abstract] [Full Text] [Related]
6. A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine.
Montgomery SA; Nielsen RZ; Poulsen LH; Häggström L
Hum Psychopharmacol; 2014 Sep; 29(5):470-82. PubMed ID: 25087600
[TBL] [Abstract][Full Text] [Related]
7. Vortioxetine.
Australas Psychiatry; 2015 Jun; 23(3):306, 315. PubMed ID: 26014624
[No Abstract] [Full Text] [Related]
8. Possible serotonin syndrome with trazodone addition to fluoxetine.
George TP; Godleski LS
Biol Psychiatry; 1996 Mar; 39(5):384-5. PubMed ID: 8704074
[No Abstract] [Full Text] [Related]
9. The safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies.
Baldwin DS; Chrones L; Florea I; Nielsen R; Nomikos GG; Palo W; Reines E
J Psychopharmacol; 2016 Mar; 30(3):242-52. PubMed ID: 26864543
[TBL] [Abstract][Full Text] [Related]
10. Vortioxetine (Brintellix) for depression.
Med Lett Drugs Ther; 2013 Nov; 55(1430):93-5. PubMed ID: 24276501
[No Abstract] [Full Text] [Related]
11. Dystonia associated with trazodone and sertraline.
Lewis CF; DeQuardo JR; Tandon R
J Clin Psychopharmacol; 1997 Feb; 17(1):64-5. PubMed ID: 9004068
[No Abstract] [Full Text] [Related]
12. Vortioxetine for the treatment of major depressive disorder.
Tritschler L; Felice D; Colle R; Guilloux JP; Corruble E; Gardier AM; David DJ
Expert Rev Clin Pharmacol; 2014 Nov; 7(6):731-45. PubMed ID: 25166025
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, duloxetine-referenced study comparing efficacy and tolerability of 2 fixed doses of vortioxetine in the acute treatment of adults with MDD.
Mahableshwarkar AR; Jacobsen PL; Chen Y; Serenko M; Trivedi MH
Psychopharmacology (Berl); 2015 Jun; 232(12):2061-70. PubMed ID: 25575488
[TBL] [Abstract][Full Text] [Related]
14. Treatment-emergent sexual dysfunction in randomized trials of vortioxetine for major depressive disorder or generalized anxiety disorder: a pooled analysis.
Jacobsen PL; Mahableshwarkar AR; Palo WA; Chen Y; Dragheim M; Clayton AH
CNS Spectr; 2016 Oct; 21(5):367-378. PubMed ID: 26575433
[TBL] [Abstract][Full Text] [Related]
15. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants.
Peet M
Br J Psychiatry; 1994 Apr; 164(4):549-50. PubMed ID: 8038948
[TBL] [Abstract][Full Text] [Related]
16. [Trazodone and venlafaxine in treatment of depressive disorders].
Florkowski A; Gruszczyński W; Gałecki P; Zboralski K; Kołodziejska I; Mikołajczyk I
Pol Merkur Lekarski; 2005 May; 18(107):556-9. PubMed ID: 16161955
[TBL] [Abstract][Full Text] [Related]
17. Randomized, 8-week, double-blind, placebo-controlled trial of vortioxetine in Japanese adults with major depressive disorder, followed by a 52-week open-label extension trial.
Inoue T; Nishimura A; Sasai K; Kitagawa T
Psychiatry Clin Neurosci; 2018 Feb; 72(2):103-115. PubMed ID: 29160598
[TBL] [Abstract][Full Text] [Related]
18. Mania from dose-related ziprasidone augmentation of an SSRI.
Privitera MR; Maharaj K
J Clin Psychiatry; 2003 Nov; 64(11):1393-4. PubMed ID: 14658958
[No Abstract] [Full Text] [Related]
19. Vortioxetine : a review of efficacy, safety and tolerability with a focus on cognitive symptoms in major depressive disorder.
Al-Sukhni M; Maruschak NA; McIntyre RS
Expert Opin Drug Saf; 2015 Aug; 14(8):1291-304. PubMed ID: 26022537
[TBL] [Abstract][Full Text] [Related]
20. Two case reports of trazodone-induced mania.
Warren M; Bick PA
Am J Psychiatry; 1984 Sep; 141(9):1103-4. PubMed ID: 6465389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
